Taylor PA - Search Results

1

CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.

Blazar BR, Taylor PA, Noelle RJ, Vallera DA. Blazar BR, et al. Among authors: taylor pa. J Clin Invest. 1998 Aug 1;102(3):473-82. doi: 10.1172/JCI3741. J Clin Invest. 1998. PMID: 9691083 Free PMC article.

2

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Taylor PA, Lees CJ, Blazar BR. Taylor PA, et al. Blood. 2002 May 15;99(10):3493-9. doi: 10.1182/blood.v99.10.3493. Blood. 2002. PMID: 11986199 Free article.

3

Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell.

Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR. Taylor PA, et al. Blood. 2002 Jun 15;99(12):4601-9. doi: 10.1182/blood.v99.12.4601. Blood. 2002. PMID: 12036894 Free article.

4

Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.

Taylor PA, Lees CJ, Wilson JM, Ehrhardt MJ, Campbell MT, Noelle RJ, Blazar BR. Taylor PA, et al. Blood. 2002 Nov 1;100(9):3400-7. doi: 10.1182/blood-2002-03-0872. Blood. 2002. PMID: 12384443 Free article.

5

Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism.

Blazar BR, Carreno BM, Panoskaltsis-Mortari A, Carter L, Iwai Y, Yagita H, Nishimura H, Taylor PA. Blazar BR, et al. Among authors: taylor pa. J Immunol. 2003 Aug 1;171(3):1272-7. doi: 10.4049/jimmunol.171.3.1272. J Immunol. 2003. PMID: 12874215

6

Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.

Godfrey WR, Krampf MR, Taylor PA, Blazar BR. Godfrey WR, et al. Among authors: taylor pa. Blood. 2004 Feb 1;103(3):1158-65. doi: 10.1182/blood-2003-04-1098. Epub 2003 Oct 2. Blood. 2004. PMID: 14525783 Free article.

7

CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.

Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA. Blazar BR, et al. Among authors: taylor pa. J Immunol. 2004 Sep 1;173(5):2933-41. doi: 10.4049/jimmunol.173.5.2933. J Immunol. 2004. PMID: 15322151

8

Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).

Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, Sharpe AH, Noelle RJ, Rudensky AY, Mak TW, Serody JS, Blazar BR. Taylor PA, et al. Blood. 2005 Apr 15;105(8):3372-80. doi: 10.1182/blood-2004-10-3869. Epub 2004 Dec 23. Blood. 2005. PMID: 15618467 Free article.

9

Regulatory T cells.

Blazar BR, Taylor PA. Blazar BR, et al. Among authors: taylor pa. Biol Blood Marrow Transplant. 2005 Feb;11(2 Suppl 2):46-9. doi: 10.1016/j.bbmt.2004.11.005. Biol Blood Marrow Transplant. 2005. PMID: 15682177 Free article. Review. No abstract available.

10

Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.

Vogtenhuber C, Bucher C, Highfill SL, Koch LK, Goren E, Panoskaltsis-Mortari A, Taylor PA, Farrar MA, Blazar BR. Vogtenhuber C, et al. Among authors: taylor pa. Blood. 2010 Jul 22;116(3):466-74. doi: 10.1182/blood-2009-11-252825. Epub 2010 May 4. Blood. 2010. PMID: 20442366 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters